Status:
COMPLETED
Rehabilitation of Everyday Memory Impairment in Parkinson Disease: A Pilot Study
Lead Sponsor:
Washington University School of Medicine
Conditions:
Parkinson's Disease
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
Cognitive impairment is common among non-demented individuals with Parkinson disease (PD) and is a significant source of disability and reduced quality of life. Unfortunately, there are no successful ...
Detailed Description
Cognitive impairment is common among non-demented individuals with Parkinson disease (PD) and is a significant source of disability and reduced quality of life. Unfortunately, there are no successful ...
Eligibility Criteria
Inclusion
- Participants will be males and females over age 50 who meet criteria for idiopathic typical PD, are Hoehn \& Yahr39 stage I-III (mild-moderate disease) and are treated with levodopa/carbidopa.
Exclusion
- Possible dementia,
- treatment with certain medications that interfere with cognition (e.g., anticholinergics),
- change in medications over the study period, other neurological disorders, brain surgery (e.g., STN DBS),
- history of psychotic disorder or significant current psychiatric disorder, or any condition that would interfere with testing (e.g., vision problems).
Key Trial Info
Start Date :
June 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2014
Estimated Enrollment :
74 Patients enrolled
Trial Details
Trial ID
NCT01469741
Start Date
June 1 2011
End Date
May 1 2014
Last Update
June 3 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University School of Medicine
St Louis, Missouri, United States, 63110